Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

Area of Science:

• Neuroscience
• Psychiatry
• Addiction Medicine

Background:

• Classic hallucinogens, specifically 5HT2A agonists like psilocybin, show potential in treating addiction.
• Previous research explored psilocybin in various populations, but its efficacy for alcohol dependence remained unstudied.

Purpose of the Study:

• To assess the acute effects of psilocybin in individuals with alcohol dependence.
• To gather preliminary data on the outcomes and safety of psilocybin-assisted therapy for alcohol dependence.

Main Methods:

• A single-group, proof-of-concept study involving ten alcohol-dependent volunteers.
• Participants received oral psilocybin alongside Motivational Enhancement Therapy, including preparation and debriefing sessions.
• Data collected on acute effects, abstinence rates, craving, and self-efficacy.

Main Results:

• Abstinence rates significantly increased after psilocybin administration (p < 0.05) and were largely maintained up to 36 weeks.
• The intensity of the initial psilocybin session strongly predicted reduced drinking and craving, and increased abstinence self-efficacy.
• No significant treatment-related adverse events were reported, indicating good safety.

Conclusions:

• Preliminary findings support psilocybin's potential as a treatment for alcohol dependence.
• The intensity of the psychedelic experience appears to be a key factor in treatment outcomes.
• Further controlled trials with larger sample sizes are warranted to confirm efficacy and explore mechanisms.